Explore adipose harvesting as your next service line.
Evaluate body contouring and adipose / stem-cell harvesting within the FunSculpting platform. Start with the equipment configuration, clinical workflow and economics for your practice.
Smart Harvest · Explore the harvesting configuration and workflow.
Build the business case around what your practice can deliver.
A harvesting service needs its own clinical plan and cost model. Assess it alongside body contouring, with clear responsibilities for your team and any outside laboratory.
Review the exact system, accessories, instructions for use and intended procedures with your clinical lead.
Define patient assessment, appropriately qualified staff, procedure time, tissue handling and follow-up responsibilities.
Separate collected procedure revenue from laboratory charges, direct costs and shared overhead before estimating margin.
Four steps to a practical launch plan.
Identify the harvesting procedure you intend to offer and the role of each clinician and partner.
Confirm the device configuration, applicable clearance, instructions and proposed laboratory services.
Discuss hands-on instruction, initial-case support, supplies and the responsibilities included in your quote.
Use expected case volume, collected prices and actual costs. Allow time to train the team and build demand.
See the contribution from harvesting separately.
The FunSculpting calculator lets you add harvesting revenue and expenses to your body-contouring model. It subtracts the shared equipment payment once.
Enter only what your practice collects. If harvesting is bundled into a body-contouring price, avoid counting that revenue twice.
Confirm the current lab quote, services included and who pays. The calculator’s $4,500 field is an unconfirmed planning placeholder.
Deduct lab charges paid by the practice, supplies, staff costs and other overhead. Gross collections are not profit.
If a patient pays the lab directly, exclude that payment from practice revenue and enter $0 for the corresponding practice-paid lab expense. Read the provider FAQs for payment-coverage examples.
Harvesting and downstream treatment are separate decisions.
This page describes evaluation of a harvesting service. It does not establish that a harvested cell product is approved or appropriate for injection, infusion or treatment of a disease.
The FDA regulates regenerative medicine products and cautions against unsupported treatment claims. Review the FDA’s regenerative medicine information with your clinical and regulatory advisers when evaluating any proposed downstream use.
Request documentation for the exact equipment and proposed service. Device clearance, laboratory processing and authorization for a particular treatment should each be reviewed on their own terms.
Bring your practice numbers. Build a clear plan.
Discuss your current services, clinical team, target volume and harvesting questions during a provider walkthrough.
Updated September 16, 2026. Financial examples are for planning. Confirm current equipment, training, laboratory and financing terms in writing.